Skip to content

Study · Case report or series · n = 2 · 2025

1 result

Ketotic Hypoglycaemia Following Sleeve Gastrectomy.

He J, Phillips L, Nisbet J, Morton A

Clinical endocrinology25 Mar 2025

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In two patients with ketotic hypoglycaemia after sleeve gastrectomy, semaglutide resolved hypoglycaemic episodes in one and significantly reduced them in the other.

    In plain wordsIn two patients with low blood sugar after stomach surgery, semaglutide stopped the episodes in one and reduced them in the other.

    Outcome
    DecreaseHypoglycaemic episodes
    Study

    n = 2

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Treatment with the glucagon-like peptide-1 receptor agonist semaglutide resulted in the resolution of hypoglycaemic episodes in one patient, and a significant reduction in hypoglycaemic episodes in the other patient.
    1 context sentence
    Summary · context
    Two cases of non-insulin mediated, ketotic hypoglycaemia following sleeve gastrectomy are presented.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.